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isoniazid, rifampin, and streptomycin. Treatment with isoniazid,Three Episodes of Tuberculosis—To Multidrug
rifampin, ethambutol, pyrazinamide, and ciprofloxacin was started;Resistance and Back to Susceptibility
therapy with the latter three drugs was continued for 12 months.
After she recovered, she traveled several times to India betweenWe report the case of a patient who had three episodes of tuber-
1990 and 1993 and subsequently worked as an assistant nurse atculosis; two of these episodes were due to resistant strains of
the University Hospital in Zurich. In the fall of 1995, she com-Mycobacterium tuberculosis, and one was due to a susceptible
plained of pain under the right scapula and developed a productivestrain.
cough, malaise, fever, and night sweats. An infiltrate was observedA 31-year-old Tibetan woman who was born in India developed
on a chest radiograph, and pulmonary TB with right-sided cervicalsmear-positive tuberculosis (TB) of the lung in 1987, 1990, and
lymphadenitis was diagnosed (episode 3). For the third time, cul-1995. Upon immigration to Switzerland in 1984, findings on her
tures were positive, but surprisingly, the M. tuberculosis isolatechest radiograph were normal. Three years later, progressive, cav-
was fully susceptible to all first-line drugs.ernous TB of the left upper lobe was diagnosed (episode 1).
This finding prompted us to study all isolates at the molecularM. tuberculosis was isolated from sputum and gastric fluid speci-
level to better understand this case. By using PvuII as the restrictionmens, and primary resistance to isoniazid was detected. The patient
enzyme and IS6110 as a probe [1], we found two different patternswas hospitalized and treated with isoniazid, rifampin, and pyra-
of restriction fragment length polymorphism (RFLP): the isolateszinamide for 2 months, followed by a regimen of rifampin and
recovered during episode 1 and episode 2 had identical DNA fin-ethambutol for 4 months. After 14 weeks of treatment, cultures
gerprints, whereas those recovered during episode 3 differed con-became negative.
siderably from the initial strains. On probing AluI-digested DNAAfter the patient recovered clinically, she traveled to India and
with the polymorphic GC-rich repetitive sequence [2], bandingNepal in 1989; however, upon her return in 1990, she developed
patterns for the isolates from episodes 1 and 2 were again founda cough and night sweats, and cavernous TB of the left upper lobe,
to differ from those of episode 3.
with laryngeal and endobronchial involvement, was diagnosed (ep-
On the basis of this case, three major conclusions can be drawn:
isode 2). The M. tuberculosis isolate proved to be resistant to
(1) Of the two episodes of TB in 1990 and 1995, only one was a
true relapse, probably caused by inadequate drug therapy. Con-
versely, episode 3 was due to exogenous reinfection. (2) Treatment
of TB after episode 2 was successful, as indicated by the significant
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strain infection during episode 3 can be safely ruled out, not only
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excludes the presence of the previous strains (resistant to isoniazid for TB control must be aimed primarily at minimizing transmis-
sion, i.e., eliminating M. tuberculosis in such environments.and to multiple drugs).
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crotic areas (figure 1). There was no fever or inguinal lymphadenopa-Inflammatory Tinea Corporis Due to Trichophyton
thy. Results of a complete blood count and blood chemistry evaluationverrucosum
were normal, and the erythrocyte sedimentation rate was 13 mm/h.
Repeated skin biopsy was performed, and results of gram and acid-
A recent report by Sabota et al. describes tinea barbae due to Tricho- fast stains as well as routine bacterial and mycobacterial cultures were
phyton verrucosum in dairy farmers [1]. T. verrucosum may also cause negative. Histopathologic evaluation demonstrated a mixed inflamma-
other infections including tinea corporis [2, 3], and other animals, such tory cell infiltrate and a fungal spore (figure 1). After 2 weeks’ incuba-
as horses, may be the source of infection [4, 5]. We describe a patient, tion at 307C, T. verrucosum was isolated. Oral itraconazole (200 mg
b.i.d.) was administered for 12 weeks, and the leg lesion resolvedwith horse contact, who developed inflammatory tinea corporis due to
completely.T. verrucosum, confirmed by histopathology and culture results.
Chronic tinea corporis is uncommon and is usually due to eitherA 54-year-old man, whose work involved riding horses in rural
Trichophyton mentagrophytes or T. verrucosum [4]. T. verrucosum isareas, presented with left leg tenderness and erythema; he had no fever
distributed globally [5], and human infection has been reported pre-or other systemic symptoms. There was no response to treatment with
viously from Australasia [6, 7]. T. verrucosum usually infects cows,oral flucloxacillin and roxithromycin. A biopsy of the leg lesion was
but it is also isolated frequently from horses [4]. In the current case,performed. A gram stain of the specimen was negative, but coagulase-
the lesion was on the patient’s leg, where there had been direct contactnegative staphylococci were isolated, and histopathology demonstrated
with a common site of horse ringworm [4]. Zoophilic dermatophytesnonspecific chronic inflammatory changes with folliculitis. Treatment
like T. verrucosum may produce inflammatory disease that can bewith flucloxacillin (1 g q6h iv) and oral ciprofloxacin (750 mg b.i.d.)
mistaken for bacterial infection [1, 5, 8]. Tinea corporis due to zoophilicwas begun, but there was no improvement in the patient’s condition.
dermatophytes may resolve spontaneously, but systemic antifungalSeven weeks after his initial presentation, he was referred to our
therapy is usually required [5, 9].institution for consideration of hyperbaric oxygen therapy for ‘‘celluli-
In cases of tinea corporis, biopsies may demonstrate cylindricaltis’’ that was not responding to therapy with antibacterial agents. Exam-
fungal filaments, or rounded arthroconidia [10], which are characteristi-ination of the medial aspect of the left leg revealed a 15 1 6-cm,
cally large in T. verrucosum infection [3]. In inflammatory tinea corpo-erythematous, indurated plaque, containing pustular lesions with ne-
ris caused by zoophilic dermatophytes such as T. verrucosum, hypersen-
sitivity reactions may produce vesicles and papules accompanied by
dermal infiltrates [10], or vasculitis characterized by small follicular
papules with necrotic areas [3]. Histopathologic features of hypersensi-
tivity reactions include infiltration of lymphocytes, plasma cells, neutro-Reprints or correspondence: Dr. Tony Korman, Department of Microbiol-
phils, and eosinophils into the dermis [10].ogy, Monash University, Clayton Victoria 3168 Australia.
Tinea corporis due to T. verrucosum should be included in the
Clinical Infectious Diseases 1998;26:220–1
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